OMGA (Omega) Long-Term Debt

Corporate emblem and logo of Omega Therapeutics Inc (OMGA)

The market price for Omega Therapeutics (OMGA) confirmed by the chart on the GURU.Markets platform helps assess the company's resilience to macroeconomic shocks, as progress in developing RNA-based drugs is independent of GDP. Monopoly potential in epigenetics provides the company with unlimited pricing power. Meanwhile, the current metric stands at 0.00, highlighting the business's pre-revenue status and rising costs associated with expanding its laboratory base.

OMGA Omega: Company Long-Term Debts in the range 07/04/2022 - 03/08/2025

Omega (OMGA) - metric breakdowns and financial figures

- price and consensus price forecast:
Stock Price omegatherapeutics.com|OMGA - Price Target Chart
- market capitalization data:
Market Value Omega Therapeutics|OMGA - Total Company Value
- book capitalization data:
Accounting Value per Share Omega Therapeutics|OMGA - Book Capitalization|Market-to-Book Ratio omegatherapeutics.com|OMGA - Company Total Assets
- debt and liquidity data:
Debt to Capital Ratio Omega Therapeutics|OMGA - Long-Term Debt to Capital|Short-Term Debt to Capital Omega Therapeutics Corp|OMGA - Company Total Debt|Debt to Net Assets Ratio Omega Therapeutics|OMGA - Company Long-Term Liabilities|Amount of Current Liabilities Omega Therapeutics
Comprehensive company analysis:OMGA - omegatherapeutics.com
Original product of Omega

The development of epigenetic drugs by Omega Therapeutics (OMGA) requires an assessment of the issuer's long-term liabilities to analyze financial stability. This indicator aggregates all credit obligations with a maturity exceeding one year. The metric measures the long-term debt load, allowing for the determination of bankruptcy risk in the event of interest rate fluctuations. The use of contract manufacturing organizations reduces capital expenditures, optimizing the borrowing structure. This trend reflects the company's ability to fund innovation without critical dependence on creditors.

Competitors of Omega Therapeutics

Tempus Labs - Company Long-Term Debts|QGEN (Qiagen) - Company Long-Term Debt|IONS: Long-Term Debt|RGEN (Repligen Corp.) - Company Long-Term Debt|Avidity Corp (RNA) - Company Long-Term Liabilities|Company Long-Term Debts CRSP (CRISPR Therapeutics AG)|Long-Term Debt genedx.com|RARE: Company Long-Term Debts|Long-Term Indebtedness Beam Therapeutics Inc (BEAM)|Company Long-Term Debts SRPT (Sarepta Therapeutics Inc)|TWST - Company Long-Term Debts|Company Long-Term Liabilities 10x Genomics, Inc. (TXG)|intelliatx.com (NTLA) - Company Long-Term Loans and Borrowings|STOK - Company Long-Term Liabilities|BioLife Solutions Inc (BLFS) - Amount of Long-Term Liabilities|WVE - Company Long-Term Debts|Company Long-Term Loans and Borrowings Maze Therapeutics Corp|Sionna Therapeutics Inc - Company Long-Term Debts|Long-Term Debt PRME (primemedicine.com)|Company Long-Term Debt Taysha Gene Therapies, Inc.|Company Long-Term Loans and Borrowings uniQure NV QURE|MeiraGTx PLC - Company Long-Term Debts|RGNX: Company Long-Term Debts|Company Long-Term Debt Solid Biosciences Inc. (SLDB)|ocugen.com (OCGN) - Long-Term Liabilities|Company Long-Term Debts PACB (PacBio)|Long-Term Debt Benitec Biopharma Inc (BNTC)|Company Long-Term Liabilities DSGN|Company Long-Term Debts Rocket Corp RCKT|Company Long-Term Liabilities 4D Molecular Therapeutics (FDMT)|Amount of Long-Term Liabilities Lexeo Therapeutics Inc. LXEO|Company Long-Term Debts KRRO (Korro Bio, Inc)|EDIT - Long-Term Debt Volume|SLN (Silence Therapeutics Inc.) - Company Long-Term Debts|PRQR (ProQR Therapeutics) - Company Long-Term Liabilities|CDXS: Company Long-Term Debt|Long-Term Debt Volume SGMO|Nautilus Biotechnology - Company Long-Term Debt|Long-Term Debt MGX (Metagenomi Inc.)|Precision BioSciences - Company Long-Term Debt|Company Long-Term Liabilities Generation Bio Co GBIO|Company Long-Term Debts BOLD|XCUR - Long-Term Indebtedness|IMNN: Company Long-Term Debts|Phio Pharmaceuticals Corp. (PHIO) - Company Long-Term Debts|Company Long-Term Debts Mustang Bio Inc (MBIO)|Company Long-Term Indebtedness RNAZ|Company Long-Term Debt Bionano Genomics, Inc. BNGO|Company Long-Term Indebtedness adnas.com (APDN)|Company Long-Term Debts BLUE (bluebird bio)|ImmunoPrecise Antibodies Ltd - Company Long-Term Debts|OMIC (Singular Genomics Systems Inc) - Company Long-Term Debt|RGLS: Long-Term Debt|SYRS (Syros Pharmaceuticals) - Company Long-Term Debt|telesisbio.com (TBIO) - Company Long-Term Liabilities|Company Long-Term Debts TCON (TRACON Pharmaceuticals, Inc.)|Long-Term Debt Unity Biotechnology Inc.